Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Assessment of dam effects on streams and fish assemblages of the conterminous USA.

Cooper AR, Infante DM, Daniel WM, Wehrly KE, Wang L, Brenden TO.

Sci Total Environ. 2017 May 15;586:879-889. doi: 10.1016/j.scitotenv.2017.02.067. Epub 2017 Feb 21.

PMID:
28233615
2.

Analysis of two monoclonal antibodies reactive with envelope proteins of murine retroviruses: one pan specific antibody and one specific for Moloney leukemia virus.

Evans LH, Boi S, Malik F, Wehrly K, Peterson KE, Chesebro B.

J Virol Methods. 2014 May;200:47-53. doi: 10.1016/j.jviromet.2014.02.006. Epub 2014 Feb 17.

3.

Landscape-based assessment of human disturbance for michigan lakes.

Wang L, Wehrly K, Breck JE, Kraft LS.

Environ Manage. 2010 Sep;46(3):471-83. doi: 10.1007/s00267-010-9525-z. Epub 2010 Jul 13.

PMID:
20625900
4.

Neurovirulence of polytropic murine retrovirus is influenced by two separate regions on opposite sides of the envelope protein receptor binding domain.

Peterson KE, Pourciau S, Du M, Lacasse R, Pathmajeyan M, Poulsen D, Agbandje-McKenna M, Wehrly K, Chesebro B.

J Virol. 2008 Sep;82(17):8906-10. doi: 10.1128/JVI.02134-07. Epub 2008 Jun 25.

5.
6.
8.

Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity.

Zhang K, Rana F, Silva C, Ethier J, Wehrly K, Chesebro B, Power C.

J Virol. 2003 Jun;77(12):6899-912.

9.
10.

N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.

Lawson VA, Priola SA, Wehrly K, Chesebro B.

J Biol Chem. 2001 Sep 21;276(38):35265-71. Epub 2001 Jul 20.

11.

Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Wong C, Xiong LW, Horiuchi M, Raymond L, Wehrly K, Chesebro B, Caughey B.

EMBO J. 2001 Feb 1;20(3):377-86.

12.

Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.

Chabry J, Priola SA, Wehrly K, Nishio J, Hope J, Chesebro B.

J Virol. 1999 Aug;73(8):6245-50.

13.

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients.

Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson RT, Chesebro B.

J Virol. 1998 Nov;72(11):9045-53.

15.
16.

The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Picchio GR, Gulizia RJ, Wehrly K, Chesebro B, Mosier DE.

J Virol. 1998 Mar;72(3):2002-9. Erratum in: J Virol 1998 Sep;72(9):7707.

17.

Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.

Speck RF, Wehrly K, Platt EJ, Atchison RE, Charo IF, Kabat D, Chesebro B, Goldsmith MA.

J Virol. 1997 Sep;71(9):7136-9.

20.

In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160.

Pincus SH, Wehrly K, Cole R, Fang H, Lewis GK, McClure J, Conley AJ, Wahren B, Posner MR, Notkins AL, Tilley SA, Pinter A, Eiden L, Teintze M, Dorward D, Tolstikov VV.

AIDS Res Hum Retroviruses. 1996 Jul 20;12(11):1041-51.

PMID:
8827220
21.
22.

Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.

Iversen AK, Shafer RW, Wehrly K, Winters MA, Mullins JI, Chesebro B, Merigan TC.

J Virol. 1996 Feb;70(2):1086-90.

23.
24.

A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP.

Priola SA, Caughey B, Wehrly K, Chesebro B.

J Biol Chem. 1995 Feb 17;270(7):3299-305.

25.

Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemia.

Perry LL, Miyazawa M, Hasenkrug K, Wehrly K, David CS, Chesebro B.

J Virol. 1994 Aug;68(8):4921-6.

27.

Foreign PrP expression and scrapie infection in tissue culture cell lines.

Chesebro B, Wehrly K, Caughey B, Nishio J, Ernst D, Race R.

Dev Biol Stand. 1993;80:131-40.

PMID:
8270103
29.

Detailed mapping of the Rfv-1 gene that influences spontaneous recovery from Friend retrovirus-induced leukaemia.

Miyazawa M, Nishio J, Wehrly K, Jay G, Melvold RW, Chesebro B.

Eur J Immunogenet. 1992 Jun;19(3):159-64.

PMID:
1627536
30.

Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice.

Robertson MN, Spangrude GJ, Hasenkrug K, Perry L, Nishio J, Wehrly K, Chesebro B.

J Virol. 1992 Jun;66(6):3271-7.

31.

Spontaneous recovery from Friend retrovirus-induced leukemia. Mapping of the Rfv-2 gene in the Q/TL region of mouse MHC.

Miyazawa M, Nishio J, Wehrly K, David CS, Chesebro B.

J Immunol. 1992 Mar 15;148(6):1964-7.

PMID:
1541833
32.

Influence of MHC genes on spontaneous recovery from Friend retrovirus-induced leukemia.

Miyazawa M, Nishio J, Wehrly K, Chesebro B.

J Immunol. 1992 Jan 15;148(2):644-7.

PMID:
1729380
33.
34.

Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus.

Sitbon M, d'Auriol L, Ellerbrok H, André C, Nishio J, Perryman S, Pozo F, Hayes SF, Wehrly K, Tambourin P, et al.

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5932-6.

35.

Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents.

Pincus SH, Wehrly K, Chesebro B.

Biotechniques. 1991 Mar;10(3):336-42.

PMID:
2064772
36.
37.

Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine.

Remington KM, Chesebro B, Wehrly K, Pedersen NC, North TW.

J Virol. 1991 Jan;65(1):308-12.

40.

Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.

Pincus SH, Wehrly K, Tschachler E, Hayes SF, Buller RS, Reitz M.

J Exp Med. 1990 Sep 1;172(3):745-57.

41.
42.
43.

Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.

Pincus SH, Wehrly K, Chesebro B.

J Immunol. 1989 May 1;142(9):3070-5.

PMID:
2540236
44.

Evidence against expression of an endogenous murine leukemia virus causing cellular resistance to lysis by activated macrophages.

Gooding LR, Taylor JR, Laster SM, Wehrly K, Chesebro B, Brickell PM, Latchmann DS, Rigby PW.

J Immunol. 1989 Jan 1;142(1):257-62.

PMID:
2535857
45.
46.

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.

Earl PL, Moss B, Morrison RP, Wehrly K, Nishio J, Chesebro B.

Science. 1986 Nov 7;234(4777):728-31.

PMID:
3490689
48.

Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain.

Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, Bergstrom S, Robbins K, Mayer L, Keith JM, et al.

Nature. 1985 May 23-29;315(6017):331-3.

PMID:
3923361
49.

Supplemental Content

Loading ...
Support Center